Status:
NOT_YET_RECRUITING
Incentive Spirometer Training in Type 2 Diabetes With Sarcopenia
Lead Sponsor:
Yu-Shan Hsieh
Conditions:
Type 2 Diabetes
Sarcopenia
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
In patients with Type 2 diabetes, the risk of developing sarcopenia is three times higher compared to individuals with normal blood sugar levels. Sarcopenia is often accompanied by reduced physical ac...
Detailed Description
In patients with Type 2 diabetes, the risk of developing sarcopenia is three times higher compared to individuals with normal blood sugar levels. Sarcopenia is often accompanied by reduced physical ac...
Eligibility Criteria
Inclusion
- Diagnosed with Type 2 diabetes (ICD-10 diagnosis codes: E10.x or E11.x)
- Screened with a score of 4 or above on the SARC-F questionnaire.
- Aged between 20-90 years old and able to communicate in Mandarin or Taiwanese
Exclusion
- Patients with a functional status grade of ≥5 on the Modified Rankin Scale (MRS), indicating severe disability or bedridden condition.
- Patients suffering from dementia, such as Alzheimer\'s disease, Parkinson\'s disease, etc.
- Patients with acute psychiatric symptoms unable to communicate.
- Currently diagnosed with chronic obstructive pulmonary disease (COPD) or any other respiratory system diseases.
- Moderate or severe heart disease (New York Heart Association functional classification Class III or IV).
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06500221
Start Date
August 1 2024
End Date
February 28 2025
Last Update
July 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.